Alcohol and psoriasis: Sobering thoughts

Clinical and Experimental Dermatology

Volumn 38, Issue 8, 2013, Pages 819-822

  Adamzik, K ^a   McAleer, M A ^a   Kirby, B ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOLISM; ANXIETY; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; HUMAN; IMMUNE DYSREGULATION; INFLAMMATION; KERATINOCYTE; LIVER TOXICITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SMOKING; TREATMENT OUTCOME;

ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; ALCOHOLISM; HUMANS; PSORIASIS; RISK FACTORS;

EID: 84888085627     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12013     Document Type: Review

References (33)

1. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
2. McAleer MA, Mason DL, Cunningham S, et al,. Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress. Br J Dermatol 2011; 164: 1256-61.
3. Tobin AM, Higgins EM, Norris S, et al,. Prevalence of psoriasis in patients with alcoholic liver disease. Clin Exp Dermatol 2009; 34: 698-701.
4. Kirby B, Richards HL, Mason DL, Fortune DG,. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 2008; 158: 138-40.
5. Organisation for Economic Co-operation and Development (OECD). Health Data, June 2011. Available at: http://www.oecd.org/document/16/0,3746,en-2649- 37407-2085200-1-1-1-37407,00.html.
6. Han DY, Fraser AG, Dryland P, et al,. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res 2010; 690: 116-22.
7. Hoovestol RA, Mikuls TR,. Environmental exposures and rheumatoid arthritis risk. Curr Rheumatol Report 2011; 13: 431-9.
8. Carmona L, Cross M, Williams B, et al,. Rheumatoid arthritis. Best Pract Res Clin Rheumatol 2010; 24: 733-45.
9. Hazes JM, Dijkmans BA, Vandenbroucke JP,. Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis 1990; 49: 980-2.
10. Quesnel S, Feinstein A,. Multiple sclerosis and alcohol: a study of problem drinking. Mult Scler 2004; 10: 197-201.
11. Goodin DS,. Survey of multiple sclerosis in Northern California. Mult Scler 1999; 5: 78-88.
12. Costenbader KH, Karlson EW,. Cigarette smoking and autoimmune disease: what can we learn from epidemiology?. Lupus 2006; 15: 737-45.
13. Kirby B, Richards HL, Mason DL, et al,. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 2008; 158: 138-46.
14. Qureshi AA, Dominguez PL, Choi HK, et al,. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol 2010; 146: 1364-9.
15. Poikolainen K, Reunala T, Karvonen J, et al,. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ 1990; 300: 780-3.
16. Poikolainen K, Karvonen J, Pukkala E,. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999; 135: 1490-3.
17. Farkas A, Kemény L,. Psoriasis and alcohol: is cutaneous ethanol one of the missing links? Br J Dermatol 2010; 162: 711-6.
18. Farkas A, Kemény L,. The alcohol metabolite acetaldehyde and psoriasis: another trigger factor? Clin Exp Dermatol 2010; 35: 923-5.
19. Ekholm O, Strandberg-Larsen K, Grønbæk M,. Influence of the recall period on a beverage-specific weekly drinking measure for alcohol intake. Eur J Clin Nutr 2011; 65: 520-5.
20. Das SK, Dhanya L, Vasudevan DM,. Biomarkers of alcoholism: an updated review. Scand J Clin Lab Invest 2008; 68: 81-92.
21. Lemmens PH,. The alcohol content of self-report and 'standard' drinks. Addiction 1994; 89: 593-601.
22. Hayes J, Koo J,. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther 2010; 23: 174-80.
23. Ronksley PE, Brien SE, Turner BJ, et al,. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. Br Med J 2011; 342: d671.
24. Huffman JC, Celano CM, Januzzi JL,. The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndrome. Neuropsychiatr Dis Treat 2010; 6: 123-36.
25. Higgins EM, Du Vivier AW,. Alcohol abuse and treatment resistance in skin disease. J Am Acad Dermatol 1994; 30: 1048.
26. Gupta MA, Schork NJ, Gupta AK, et al,. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28: 730-2.
27. Montaudié H, Sbidian E, Paul C, et al,. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol 2011; 24: 12-8.
28. Grønhøj Larsen F, Steinkjer B, Jakobsen P, et al,. Acitretin is converted to etretinate only during concomitant alcohol intake. Br J Dermatol 2000; 143: 1164-9.
29. Zaghloul SS, Goodfield MJ,. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004; 140: 408-14.
30. Lewis MJ,. Alcohol reinforcement and neuropharmacological therapeutics. Alcohol Alcohol 1996; 31: 17-25.
31. Davis L, Uezato A, Newell JM, et al,. Major depression and comorbid substance use disorders. Curr Opin Psychiatry 2008; 21: 14-8.
32. Lewis MJ,. Alcohol and nutrient intake: mechanisms of reinforcement and dependence. Physiol Behav 2011; 104: 138-42.
33. Richards HL, Fortune DG, Griffiths CE, et al,. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11-5.